FMR LLC 13D and 13G filings for Cogent Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-12 09:28 am Purchase | 2024-12-31 | 13G | Cogent Biosciences, Inc. COGT | FMR LLC | 16,569,256 15.000% | 3,360,284 (+25.44%) | Filing |
| 2024-11-07 09:24 am Purchase | 2024-11-06 | 13G | Cogent Biosciences, Inc. COGT | FMR LLC | 13,208,972 12.068% | 4,889,561 (+58.77%) | Filing |
| 2024-11-07 09:12 am Purchase | 2024-11-06 | 13G | Cogent Biosciences, Inc. COGT | FMR LLC | 8,319,411 7.601% | 3,016,557 (+56.89%) | Filing |
| 2024-02-09 08:50 am Purchase | 2024-02-08 | 13G | Cogent Biosciences, Inc. COGT | FMR LLC | 5,302,854 6.157% | 5,302,854 (New Position) | Filing |